Valneva (VALN) Q2 2026 Earnings Call Transcript
Restructuring efforts and Lyme vaccine regulatory timeline take center stage.
We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.
More in Finance & Markets
The U.S. Bond Crisis Highlights a Deeper Fiscal Rot
Scott Bessent is breaking the glass to check rising bond yields, but the fix is flawed.
Bragg Gaming (BRAG) Q2 2026 Earnings Call Transcript
CEO Mazij prioritized margins over growth while completing Drayton acquisition.
Pakistan expects up to $100 million under first DPR programme
In a significant development for Pakistan’s external financing landscape, a project agreement between the International Finance Corporation (IFC) and Bank Alfalah Limited (BAFL) for Pakistan’s first…
THEO is Now Live on Hydrex — Autheo’s Internet Operating System Token Begins Trading
Unlike many blockchain projects that enter the public markets before meaningful adoption, THEO launches into an operational ecosystem — powering Autheo’s Intern
ADC Therapeutics (ADCT) Q2 2026 Earnings Call Transcript
FDA raised safety concerns about ZYNLONTA combination therapy in LOTIS-5 trial.